Fred Aslan
President and CEO at Artiva Biotherapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Artiva Biotherapeutics Inc., 2 years.
Chief executive roles
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 2, 2026 | Artiva Biotherapeutics Inc. | Open-market sale | −62,178 | $4.18 | $259,972 |
| Oct 6, 2026 | Artiva Biotherapeutics Inc. | Open-market sale | −23,463 | $7.20 | $168,880 |
| Oct 5, 2026 | Artiva Biotherapeutics Inc. | Open-market sale | −61,696 | $6.84 | $421,828 |
| Sep 15, 2026 | Artiva Biotherapeutics Inc. | Grant or award | +110,000 | — | — |
| Sep 10, 2026 | Artiva Biotherapeutics Inc. | Grant or award | +45,000 | — | — |
| Sep 8, 2026 | Artiva Biotherapeutics Inc. | Open-market sale | −23,429 | $10.92 | $255,845 |
| Sep 3, 2026 | Artiva Biotherapeutics Inc. | Open-market sale | −61,888 | $11.16 | $690,670 |
| May 19, 2026 | Artiva Biotherapeutics Inc. | Open-market sale | −27,116 | $9.01 | $244,315 |
| Feb 15, 2026 | Artiva Biotherapeutics Inc. | Grant or award | +366,850 | — | — |
| Feb 15, 2026 | Artiva Biotherapeutics Inc. | Shares withheld for tax | −14,600 | $4.00 | $58,400 |
| Dec 15, 2025 | Artiva Biotherapeutics Inc. | Open-market sale | −3,187 | $6.00 | $19,122 |
| Dec 12, 2025 | Artiva Biotherapeutics Inc. | Grant or award | +869,136 | — | — |
| Nov 17, 2025 | Artiva Biotherapeutics Inc. | Open-market sale | −6,375 | $3.38 | $21,548 |
| Nov 15, 2025 | Artiva Biotherapeutics Inc. | Shares withheld for tax | −6,347 | $3.25 | $20,628 |
| Oct 17, 2025 | Artiva Biotherapeutics Inc. | Open-market sale | −25,500 | $6.00 | $153,000 |
Questions about Fred Aslan
What boards is Fred Aslan on?
Fred Aslan sits on the board of Artiva Biotherapeutics Inc.
What company is Fred Aslan the CEO of?
Fred Aslan has been President and CEO of Artiva Biotherapeutics Inc. since July 2024.
How long has Fred Aslan served on boards?
Our records show at least 2 years of board service across 1 board, the earliest from 2024.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.